Holen Sie sich die Stockscreener-App
56.50
1.30%
0.7864
Schlusskurs vom Vortag:
$55.71
Offen:
$55.94
24-Stunden-Volumen:
34,282
Relative Volume:
0.35
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.38%
1M Leistung:
-0.66%
6M Leistung:
+19.36%
1J Leistung:
+28.96%
1-Tages-Spanne:
$55.72
$56.64
1-Wochen-Bereich:
$55.13
$58.53
52-Wochen-Spanne:
$35.22
$58.84
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
State Street Spdr S P Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
56.50 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
338.57 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
686.11 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
689.25 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
275.34 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
611.56 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
Most and least shorted healthcare stocks with up to $2B market cap in February - Seeking Alpha
Stock Market Today: Dow Jones, S&P500, Nasdaq Futures Decline After SC Strikes Down Trump's Emergency Tariffs— NVO, MSTR, VNDA In Focus (UPDATED) - Benzinga
XPH’s 29% Run Looks Tempting, But The 5y Chart Is A Warning - AOL.com
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development - Stocktwits
PTC Therapeutics Faces Translarna Setback While Valuation Signals Potential Upside - simplywall.st
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
Why Vertex Pharmaceuticals (VRTX) Is Up 6.0% After Profit Rebound And Non-CF Pipeline UpdateAnd What's Next - simplywall.st
Harmony Biosciences Gains Pediatric WAKIX Approval As Valuation Draws Attention - simplywall.st
NATCO Pharma Limited Just Missed Revenue By 8.4%: Here's What Analysts Think Will Happen Next - simplywall.st
Most and least shorted healthcare stocks with up to $2B market cap - Seeking Alpha
Rohto Pharmaceutical Co.,Ltd. Just Beat EPS By 6.6%: Here's What Analysts Think Will Happen Next - simplywall.st
XLP vs. FTXG: The Clash of Consumer Staple ETFs - AOL.com
Zealand Pharma A/S (CPH:ZEAL) most popular amongst retail investors who own 46% of the shares, institutions hold 38% - simplywall.st
Arrowhead Pharmaceuticals (ARWR) Valuation Check After Earnings Jump And S&P Index Move - simplywall.st
SPDR's Aerospace & Defense ETF Took An Unusual Approach That Smoked The S&P 500 With 54% Run - 24/7 Wall St.
XPH Should I Buy - Intellectia AI
The top performing pharma and biotech stocks as group sees resurgence (PJP:NYSEARCA) - Seeking Alpha
Most and least shorted mid-to mega-cap healthcare stocks in January - Seeking Alpha
Should State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar? - Yahoo Finance
Analysts Expect Breakeven For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Before Long - simplywall.st
Should State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) be on your investing radar? - MSN
Arrowhead Joins S&P 400 As Profitability Shifts Investor Focus - simplywall.st
Should You Invest in the State Street SPDR S&P Regional Banking ETF (KRE)? - Yahoo Finance
Is State Street SPDR S&P Regional Banking ETF (KRE) a Strong ETF Right Now? - Yahoo Finance
XLP Delivers Pure-Play Staples While IYK Adds Healthcare. Which Strategy Wins? - AOL.com
Is State Street SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now? - Yahoo Finance
The 10 Best Performing ETFs Over the Last 10 Years - YCharts
How Investors Are Reacting To ARS Pharmaceuticals (SPRY) Expanded EU Pediatric Nod For Needle-Free Anaphylaxis Treatment - simplywall.st
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now? - MSN
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
Pharma stocks are close to ‘breaking out.’ Earnings could set them free. - MSN
Pharma Stocks Are Close to Breaking Out. Earnings Could Set Them Free. - Barron's
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - sharewise.com
Invesco’s PXH ETF Jumped 38% as Emerging Markets Finally Heat Up - AOL.com
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan - sharewise.com
XPH: Healthcare Dashboard For January (NYSEARCA:XPH) - Seeking Alpha
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
5 Biggest Clean Energy ETFs in 2026 - Investing News Network
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report - FinancialContent
Should You Invest in the State Street SPDR S&P Semiconductor ETF (XSD)? - Yahoo Finance
ValuEngine Weekly Market Summary And Commentary - Seeking Alpha
01/12/2026 ValuEngine Weekly Market Summary & Commentary - The Globe and Mail
‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News. - Barron's
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
Better Small-Cap Growth ETF: Vanguard's VBK vs. State Street's SLYG - The Globe and Mail
Is Fidelity’s Health Care ETF A Good Buy Right Now? - AOL.com
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Finanzdaten der State Street Spdr S P Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für State Street Spdr S P Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):